Literature DB >> 17885787

Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.

Yasuhiro Ito1, Takuya Higashiyama, Yuuki Takamura, Akihiro Miya, Kaoru Kobayashi, Fumio Matsuzuka, Kanji Kuma, Akira Miyauchi.   

Abstract

BACKGROUND: Although papillary carcinoma usually shows mild characteristics, it metastasizes and shows recurrence to the lymph node in high incidences. Of the two representative lymph node compartments to which papillary carcinoma metastasizes, the central compartment can be routinely dissected via the surgical incision made for thyroidectomy. However, the routine application of prophylactic lateral node dissection (modified radical neck dissection [MND]) remains controversial. In this study, we investigated risk factors for lymph node recurrence of papillary carcinoma to determine the appropriate application of prophylactic MND.
METHODS: We investigated risk factors for lymph node recurrence in 1,231 patients without preoperatively detectable lateral node metastasis who underwent thyroidectomy, central node dissection, and prophylactic MND for papillary carcinoma between 1987 and 1995.
RESULTS: The incidence of lateral node metastasis and the number of metastatic lateral nodes significantly increased with carcinoma size. The lymph node disease-free survival (LN-DFS) was also significantly worse in carcinoma with a maximal diameter greater than 3 cm. Massive extrathyroid extension, male gender, and age 55 years or older also reflected a poorer LN-DFS. The 10-year LN-DFS rates of patients with carcinoma having two and three or four of these features were low at 88.5% and 64.7%, respectively, although the rates of those with carcinoma having no or only one characteristic were better than 95%.
CONCLUSIONS: Prophylactic MND is recommended for cases of papillary carcinoma demonstrating two or more of the following four characteristics; male gender, age 55 years or older, maximal tumor diameter larger than 3 cm, and massive extrathyroid extension.

Entities:  

Mesh:

Year:  2007        PMID: 17885787     DOI: 10.1007/s00268-007-9224-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  28 in total

Review 1.  Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

2.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

3.  Papillary carcinoma of the thyroid. I. Developing pattern of metastasis.

Authors:  S Noguchi; A Noguchi; N Murakami
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

4.  Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.

Authors:  John M Stulak; Clive S Grant; David R Farley; Geoffrey B Thompson; Jon A van Heerden; Ian D Hay; Carl C Reading; J William Charboneau
Journal:  Arch Surg       Date:  2006-05

5.  The role of ansa-to-recurrent-laryngeal nerve anastomosis in operations for thyroid cancer.

Authors:  A Miyauchi; K Matsusaka; M Kihara; F Matsuzuka; K Hirai; T Yokozawa; K Kobayashi; A Kobayashi; K Kuma
Journal:  Eur J Surg       Date:  1998-12

6.  Safety of modified radical neck dissection for differentiated thyroid carcinoma.

Authors:  Michael E Kupferman; D Michael Patterson; Susan J Mandel; Virginia LiVolsi; Randal S Weber
Journal:  Laryngoscope       Date:  2004-03       Impact factor: 3.325

7.  Recurrent laryngeal nerve palsy in thyroid gland surgery related to operations and nerves at risk.

Authors:  H Mårtensson; J Terins
Journal:  Arch Surg       Date:  1985-04

8.  Prognosis in thyroid carcinoma.

Authors:  K O Franssila
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

9.  Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age.

Authors:  F Bacourt; B Asselain; J C Savoie; E D'Hubert; J P Massin; G Doucet; A Leger; H Garnier
Journal:  Br J Surg       Date:  1986-04       Impact factor: 6.939

10.  Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping.

Authors:  Yasuhiro Ito; Akira Miyauchi; Tomoo Jikuzono; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kiyoshi Ichihara; Kanji Kuma
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

View more
  82 in total

1.  Pattern of initial metastasis in the cervical lymph node from papillary thyroid carcinoma.

Authors:  Naoyoshi Onoda; Tetsuro Ishikawa; Hidemi Kawajiri; Tsutomu Takashima; Kosei Hirakawa
Journal:  Surg Today       Date:  2012-06-26       Impact factor: 2.549

2.  Decreased expression of p27 is associated with malignant transformation and extrathyroidal extension in papillary thyroid carcinoma.

Authors:  Sung-Im Do; Dong Hyun Kim; Jung-Ho Yang; Jung-Soo Pyo; Kyungeun Kim; Hyunjoo Lee; In-Gu Do; Dong-Hoon Kim; Seoung Wan Chae; Jin Hee Sohn
Journal:  Tumour Biol       Date:  2015-10-07

3.  Prediction of central lymph node metastasis in 392 patients with cervical lymph node-negative papillary thyroid carcinoma in Eastern China.

Authors:  Yingying Xiang; Kuailu Lin; Siyang Dong; L I Qiao; Qiuxiang He; Xiaohua Zhang
Journal:  Oncol Lett       Date:  2015-07-29       Impact factor: 2.967

4.  Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.

Authors:  Yasuhiro Ito; Takumi Kudo; Kaoru Kobayashi; Akihiro Miya; Kiyoshi Ichihara; Akira Miyauchi
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

5.  Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara.

Authors:  L Pagano; M Caputo; M T Samà; V Garbaccio; M Zavattaro; M G Mauri; F Prodam; P Marzullo; R Boldorini; G Valente; G Aimaretti
Journal:  Endocrine       Date:  2012-10       Impact factor: 3.633

6.  Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma.

Authors:  Li-Qun Gu; Feng-Ying Li; Lin Zhao; Yun Liu; Qian Chu; Xun-Xiong Zang; Jian-Min Liu; Guang Ning; Yong-Ju Zhao
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

7.  Prophylactic level II neck dissection guided by frozen section for clinically node-negative papillary thyroid carcinoma: is it useful?

Authors:  Dana M Hartl; Abir Al Ghuzlan; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Martin Schlumberger
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

8.  Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Akira Yoshida
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

9.  Aberrant expression pattern and location of cullin 1 are associated with the development of papillary carcinoma in thyroid and cyclin D1 expression.

Authors:  Sung-Im Do; Kyungeun Kim; Hyunjoo Lee; Hyun-Soo Kim; Tae Gu Do; Jisup Yun; Dong-Hoon Kim; Seoung Wan Chae; Yong Lai Park; Chan Heun Park; Jin Hee Sohn; Kyueng-Whan Min; Jung-Soo Pyo
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

Review 10.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.